President Obama signed a bill that will provide US$6 billion in federal funding for basic medical research on Dec. 13. Called the 21st Century Cures Act, it also introduces changes to how the Food and Drug Administration approves drugs and medical de ...
The estimated number of visually impaired people in the world is 285 million, with 39 million blind people. About 65 percent of visually impaired people and 82 percent of all blind people are 50 years or older. Four major blinding diseases are age-re ...
Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pan ...
Cannabis Science Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announced that it has commenced production of multiple strains of cannabis and European Union certified hemp vari ...
The seriousness of disease often results from the strength of the immune response, rather than with the virus, itself. Turning down that response, rather than attacking the virus, might be a better way to reduce that severity, said Juliet Morrison of ...
Proteins are chains of amino acids that, when folded into certain structural patterns and also when unfolded, exert functions within cells. Proteins receive signals that are transmitted from one to the next and that are essential for life. However, w ...
Doctors may have found a way to help young breast cancer patients avoid infertility caused by chemotherapy. Giving a drug to shut down the ovaries temporarily seems to boost the odds they will work after treatment ends, and it might even improve surv ...
A new report shows the structure of a promising anticancer compound, TIC10, differs subtly but importantly from a previously published version. (Source: Scripps Research Institute)Chemists at The Scripps Research Institute (TSRI) have determined the ...
Johns Hopkins researchers say that an experimental anticancer compound appears to have reversed behaviors associated with schizophrenia and restored some lost brain cell function in adolescent mice with a rodent version of the devastating mental illn ...